Answer
Guselkumab (Tremfya) is indicated to treat adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.
Sources for this answer
- Tremfya 100 mg OnePress solution for injection in pre-filled penJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.1 Therapeutic Indications · Version 16Document updated
Sources checked